In a landmark update, the NCCN has added two noninvasive tests—ColoSense and Shield—to its official colorectal cancer screening guidelines. ✅…
Browsing: Clinical Updates
A rising tide of evidence suggests that complementary and mind-body therapies may be quietly transforming how we treat gastrointestinal (GI)…
Guardant Health just unveiled nearly a dozen new capabilities for its Guardant360® Liquid blood test—turning a routine draw into a…
Screening for colorectal cancer just got radically easier. New Day Diagnostics has launched ColoHealth™, a first-of-its-kind blood test available direct-to-consumer—no…
At DDW 2025, researchers unveiled a blood-based risk score that can predict the onset of Crohn’s disease (CD) up to…
In what could signal a paradigm shift in GI bleeding management, South Korea-based Nextbiomedical has published results in GUT showing…
Imagine diagnosing upper GI bleeding without an endoscopy. A new ingestible capsule, PillSense, is doing just that—providing real-time detection of…
Biomerica (NASDAQ: BMRA) reported significant real-world data for its inFoods® IBS diagnostic-guided therapy, showing remarkable symptom reduction in IBS patients. Data from…
PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Guardant…
Groundbreaking research has spotlighted IgA-coated vesicles as pivotal contributors to the chronic inflammation characteristic of ulcerative colitis, offering a transformative…